Jounce Therapeutics, Inc. announced that Elizabeth Trehu, M.D., the company's chief medical officer, is expected to resign from her role at the company as of a date that was not determinable at the time of such disclosure.
Jounce Therapeutics, Inc.
Equities
JNCE
US4811161011
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.02% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |